2YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
ZK200775 | FANAPANEL | 161605-73-8 |
Pyridostatin hydrochloride | PYRIDOSTATIN HYDROCHLORIDE | 1781882-65-2 |
TL13-110 | TL 13-110 | 2229037-09-4 |
Nω-Propyl-L-arginine hydrochloride | NW-PROPYL-L-ARGININE HYDROCHLORIDE | 2321366-46-3 |
MK-386 | (4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)-7-[(1R)-1,5-Dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-2H-indeno[5,4-f]quinolin-2-one | 158493-17-5 |
1(S),9(R)-()-Bicuculline methchloride | 38641-83-7 | |
UCM 707 | (5Z,8Z,11Z,14Z)-N-(3-FURANYLMETHYL)-5,8,11,14-EICOSATETRAENAMIDE | 390824-20-1 |
TC HSD 21 | TC HSD 21 | 330203-01-5 |
L-692585 | 化合物 T22898 | 145455-35-2 |
THIQ | THIQ | 312637-48-2 |
(D-Phe12,Leu14)-Bombesin | (D-PHE12,LEU14)-BOMBESIN | 108437-88-3 |
TM N1324 | 1144477-35-9 | 1144477-35-9 |
TC-E 5006 | 化合物 T23431 | 1257395-14-4 |
8-M-PDOT | 化合物 T10198 | 134865-70-6 |
AKT Kinase Inhibitor | AKT 激酶抑制剂 | 842148-40-7 |
Mirk-IN-1 | 1386979-55-0 | 1386979-55-0 |
MSC-2032964A | 1124381-43-6 | 1124381-43-6 |
VU0467485 | VU0467485 | 1451994-10-7 |
MitoNeoD | 2375088-89-2 | |
W-K-Y-M-V-M-NH2 | H-TRP-LYS-TYR-MET-VAL-MET-NH2 | 187986-11-4 |
PF 184 | PF 184 | 1187460-81-6 |
SLM6031434 HCl | (2S)-2-[3-[4-(Octyloxy)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]-1-pyrrolidinecarboximidamide hydrochloride | 1897379-34-8 |
SAK3 | Ethyl 8'-methyl-2',4-dioxo-2-(piperidin-1-yl)-2'H-spiro[cyclopent[2]ene-1,3'-imidazo[1,2-a]pyridine]-3-carboxylate | 1256269-87-0 |
PROTAC PD-1/PD-L1 degrader-1 | 2447066-37-5 | 2447066-37-5 |
Senexin A | 1780390-76-2 | |
MK 0343 | MK 0343 | 233275-76-8 |
SJF 1521 | 2230821-40-4 | |
SB 699551 dihydrochloride | N-[2-(Dimethylamino)ethyl]-N-[[4′-[[(2-phenylethyl)amino]methyl][1,1′-biphenyl]-4-yl]methyl]-cyclopentanepropanamide dihydrochloride | 864741-95-7 |
VU0424465 | 化合物 T29136 | 1428630-85-6 |
SB 706375 | 化合物 T23326 | 733734-61-7 |
UCL1684dibromide | 6,12,19,20,25,26-HEXAHYDRO-5,27:13,18:21,24-TRIETHENO-11,7-METHENO-7H-DIBENZO [B,N] [1,5,12,16]TETRAAZACYCLOTRICOSINE-5,13-DIIUM DIBROMIDE | 199934-16-2 |
S07662 | 1-[(2-methyl-1-benzofuran-3-yl)methyl]-3-(thiophen-2-ylmethyl)urea | 883226-64-0 |
TFC-007 | TFC 007 | 927878-49-7 |
(+/-)-PPCC oxalate | (+/-)-PPCC OXALATE | 932736-91-9 |
SAH-EZH2 | SAH-EZH2 | 1453222-26-8 |
MRS5698 | (1S,2R,3S,4R,5S)-4-[6-[[(3-Chlorophenyl)methyl]amino]-2-[2-(3,4-difluorophenyl)ethynyl]-9H-purin-9-yl]-2,3-dihydroxy-N-methylbicyclo[3.1.0]hexane-1-carboxamide | 1377273-00-1 |
S 38093 | 1403835-45-9 | |
Ro 15-4513 | RO 15-4513 | 91917-65-6 |
MPro N3 | L-Leucinamide, N-[(5-methyl-3-isoxazolyl)carbonyl]-L-al | 884650-98-0 |
Ro 51 | 2-[[4-氨基-5-[5-碘-4-甲氧基-2-(异丙基)苯氧基]-2-嘧啶基]氨基]-1,3-丙二醇 | 1050670-85-3 |
NPEC-caged-(1S,3R)-ACPD | NPEC-caged-(1S,3R)-ACPD | 1315379-60-2 |
Org 25543 hydrochloride | Org 25543 hydrochloride | 495076-64-7 |
NSC 625987 | NSC 625987 | 141992-47-4 |
P1075 | 化合物P-1075 | 60559-98-0 |
MPPG;(RS)-α-Methyl-4-phosphonophenylglycine | 169209-65-8 | |
ReZolve-ER | 1404104-40-0 | |
PHA 543613 hydrochloride | 1586767-92-1 | |
TB-21007 | TB 21007 | 207306-50-1 |
(2R,4R)-APDC | (2R,4R)-APDC | 169209-63-6 |
GGsTop | GGSTOPTM | 926281-37-0 |
TC-SP 14 | TC-SP 14 | 1257093-40-5 |
WYE-687dihydrochloride | WYE-687二盐酸盐 | 1702364-87-1 |
NBQX | 6 -硝基- 7 - 硫氨基苯并[F]喹喔啉-2,3二酮 | 479347-86-9 |
PSB 069 | 化合物 T23194 | 78510-31-3 |
Lck Inhibitor | 6-(2,6-二甲基苯基)-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-嘧啶并[5',4':5,6]嘧啶并[1,2-A]苯并咪唑-5(6H)-酮 | 847950-09-8 |
PTAC oxalate | PTAC oxalate | 201939-40-4 |
YS-035 hydrochloride | YS-035 HYDROCHLORIDE | 89805-39-0 |
(RS)-3,4-DCPG | (RS)-3,4-DCPG | 176796-64-8 |
Tabimorelin Hemifumarate | ZAMFSXBNVAXUFA-MQPYLJKMSA-N | 242143-80-2 |
SC 19220 | SC 19220 | 19395-87-0 |
FITC Phalloidin | 荧光素,鬼笔环肽 | 915026-99-2 |
NVS-CECR2-1 | NVS-CECR2-1 | 1992047-61-6 |
LY288513 | LY288513 | 147523-65-7 |
MPDC | MPDC | 159262-32-5 |
PSB 0788 | 化合物 T23197 | 1027513-54-7 |
TAPI2 | 689284-12-6 | |
SF7-AM | SF7-AM | 1416872-50-8 |
OXF BD 02 | OXF BD 02 | 1429129-68-9 |
SSM 3 trifluoroacetate | 2320930-10-5 | |
TBK1 control PROTAC4 | TBK1 CONTROL PROTAC 4 | 2052306-31-5 |
TC ASK 10 | 化合物 T13099 | 1005775-56-3 |
MI-14 | MI 14 | 1715934-43-2 |
M62812 | 6-(2-AMINOPHENOXY)-1,2-BENZOTHIAZOL-3-AMINE DIHYDROCHLORIDE | 613263-00-6 |
RG-102240 | 2-Ethyl-3-methoxybenzoic acid 2-(3,5-dimethylbenzoyl)-2-(1,1-dimethylethyl)hydrazide | 162326-49-0 |
SJF 1528 | SJF 1528 | 2230821-38-0 |
SB 204070 | 化合物 T23311 | 148688-01-1 |
TPMPA | TPMPA | 182485-36-5 |
N-MPPP Hydrochloride | 化合物 T23043 | 207452-97-9 |
MSOP | MSOP | 66515-29-5 |
Ro 04-5595 hydrochloride | Ro 04-5595 hydrochloride | 64047-73-0 |
Neurodazine | 2-[5-(3-Chlorophenyl)-2-furanyl]-4,5-bis(4-methoxyphenyl)-1H-imidazole | 937807-66-4 |
NS 5806 | NS 5806 | 426834-69-7 |
XY018 | 化合物 T24213 | 1873358-87-2 |
(1S,3R)-ACPD | 反-(1S,3R)-1-氨基-1,3-环戊烷二羧酸 | 111900-32-4 |
Ethyl (R)-5-(2,2-Dimethyltetrahydro-2H-pyran-4-yl)-1H-indole-2-carboxylate | (R)-5-(2,2-二甲基四氢-2H-吡喃-4-基)-1H-吲哚-2-甲酸乙酯 | 2758661-69-5 |
RA-839 | 化合物 T28497 | 1832713-02-6 |
EP-128495 | N-(4-甲氧基苯基)-N,2-二甲基-4-喹唑啉胺盐酸盐 | 917369-31-4 |
Vatalanib succinate | 琥珀酸瓦他拉尼 | 212142-18-2 |
PD-118057 | PD-118057 | 313674-97-4 |
MRK-016 | 342652-67-9 | 342652-67-9 |
NAV26 | 2,3-Dihydro-3-oxo-2-(tetrahydro-2H-pyran-4-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]-1H-Isoindole-1-carboxamide | 1198160-14-3 |
ZK 164015 | 2-(4-HYDROXYPHENYL)-3-METHYL-1-[10-(PENTYLSULFONYL)DECYL]-1H-INDOL-5-OL | 177583-70-9 |
YM 298198 hydrochloride | YM 298198 HYDROCHLORIDE | 1216398-09-2 |
SHA 68 | SHA 68 | 847553-89-3 |
TC-E 5008 | 1-Hydroxy-4-methyl-6-(phenylmethyl)-2-(1H)pyridinone | 50405-58-8 |
ZD 9379 | 7-CHLORO-2,3-DIHYDRO-2-(4-METHOXY-2-METHYLPHENYL)PYRIDAZINO [4,5-B] QUINOLINE-1,4,10(5H)TRIONE | 170142-20-8 |
UBP 301 | (AS)-ALPHA-AMINO-3-[(4-CARBOXYPHENYL)METHYL]-3,4-DIHYDRO-5-IODO-2,4-DIOXO-1(2H)-PYRIMIDINEPROPANOIC ACID | 569371-10-4 |
UNC 2327 | UNC2327 | 1426152-53-5 |
PDD00017272 | 1945950-20-8 | |
(S)-1-(4-FLUORO-1-METHYL-1H-INDAZOL-5-YL)-3-(2-(4-FLUORO-3,5-DIMETHYLPHENYL)-4-METHYL-4,5,6,7-TETRAH | (S)-1-(4-FLUORO-1-METHYL-1H-INDAZOL-5-YL)-3-(2-(4-FLUORO-3,5-DIMETHYLPHENYL)-4-METHYL-4,5,6,7-TETRAH | 2212022-57-4 |
联系方式